Replies to post #1325 on Entremed (ENMD)

[nottadoc2]

Cycle dude good call,
maybe I need to understand this cycle stuff.
I'm also wondering whether this could be/has been
CELG just picking up enough shares cheap to assure majority control--which would not necessarily be good in my view--they could then cause ENMD to drag its feet on 2ME while they rack up $$$ on Thalidomid and the Revlimid. Hate to be cynical but then I thought Merck was a great company until recently.If CELG got over 50% though I think thet'd have to announce it.